Breast Cancer Resistance Protein Bcrp Substrates + Vanzacaftor Tezacaftor And Deutivacaftor Interaction
Moderateinteraction on record
Description
Monitor more frequently for adverse reactions. Vanzacaftor and deutivacaftor are BCRP inhibitors in vitro that may increase exposure of BCRP substrates.
Mechanism
BCRP inhibition may increase substrate exposure
Source: NLP:vanzacaftor, tezacaftor, and deutivacaftor